The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Open accessAbstract
Nucleic acid aptamers have minimal immunogenicity, high chemical synthesis production, low cost and high chemical stability when compared with antibodies. However, the susceptibility to nuclease degradation, rapid excretion through renal filtration and insufficient binding affinity hindered their development as drug candidates for therapeutic applications. In this review, we will discuss methods to conquer these challenges and highlight recent developments of chemical modifications and technological advances that may enable early aptamers to be translated into clinical therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204026 · Cited by 929
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
El-Sagheer, A. H., & Brown, T. (2010) · Chemical Society Reviews · doi:10.1039/b901971p · Cited by 739
Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K., & Fukuzawa, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205623200 · Cited by 731
Obika, S., Nanbu, D., Hari, Y., Morio, K.-I., In, Y., Ishida, T., & Imanishi, T. (1997) · Tetrahedron Letters · doi:10.1016/s0040-4039(97)10322-7 · Cited by 610
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Kimoto, M., Yamashige, R., Matsunaga, K.-I., Yokoyama, S., & Hirao, I. (2013) · Nature Biotechnology · doi:10.1038/nbt.2556 · Cited by 510
Reyes-Reyes, E. M., Teng, Y., & Bates, P. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0920 · Cited by 383
Modified deoxyoligonucleotides stable to exonuclease degradation in serum
Shaw, J.-P., Kent, K., Bird, J., Fishback, J., & Froehler, B. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.4.747 · Cited by 369
Usman, N., Ogilvie, K. K., Jiang, M. Y., & Cedergren, R. J. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00259a037 · Cited by 366
[15] Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method
Caruthers, M. H., Barone, A. D., Beaucage, S. L., Dodds, D. R., Fisher, E. F., McBride, L. J., Matteucci, M., Stabinsky, Z., & Tang, J.-Y. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54081-2 · Cited by 344
In vitro selection with artificial expanded genetic information systems
Sefah, K., Yang, Z., Bradley, K. M., Hoshika, S., Jiménez, E., Zhang, L., Zhu, G., Shanker, S., Yu, F., Turek, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311778111 · Cited by 330
Expanding the Chemistry of DNA for in Vitro Selection
Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K., & Eaton, B. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908035g · Cited by 313
Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026332 · Cited by 310
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Gilbert, J. C., DeFeo-Fraulini, T., Hutabarat, R. M., Horvath, C. J., Merlino, P. G., Marsh, H. N., Healy, J. M., BouFakhreddine, S., Holohan, T. V., & Schaub, R. G. (2007) · Circulation · doi:10.1161/circulationaha.107.724864 · Cited by 286
Griffin, L., Tidmarsh, G., Bock, L., Toole, J., & Leung, L. (1993) · Blood · doi:10.1182/blood.v81.12.3271.3271 · Cited by 285
Green, L. S., Jellinek, D., Bell, C., Beebe, L. A., Feistner, B. D., Gill, S. C., Jucker, F. M., & Janjić, N. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90032-2 · Cited by 284
Campbell, M. A., & Wengel, J. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15048k · Cited by 279
Structural basis of substrate discrimination and integrin binding by autotaxin
Hausmann, J., Kamtekar, S., Christodoulou, E., Day, J. E., Wu, T., Fulkerson, Z., Albers, H. M. H. G., van Meeteren, L. A., Houben, A. J. S., van Zeijl, L., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1980 · Cited by 278
Sacca, B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki257 · Cited by 259
Davies, D. R., Gelinas, A. D., Zhang, C., Rohloff, J. C., Carter, J. D., O’Connell, D., Waugh, S. M., Wolk, S. K., Mayfield, W. S., Burgin, A. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213933109 · Cited by 256
Hoellenriegel, J., Zboralski, D., Maasch, C., Rosin, N. Y., Wierda, W. G., Keating, M. J., Kruschinski, A., & Burger, J. A. (2014) · Blood · doi:10.1182/blood-2013-03-493924 · Cited by 242
Click Nucleic Acid Ligation: Applications in Biology and Nanotechnology
El-Sagheer, A. H., & Brown, T. (2012) · Accounts of Chemical Research · doi:10.1021/ar200321n · Cited by 223
Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
Pagratis, N. C., Bell, C., Chang, Y.-F., Jennings, S., Fitzwater, T., Jellinek, D., & Dang, C. (1997) · Nature Biotechnology · doi:10.1038/nbt0197-68 · Cited by 221
Embracing proteins: structural themes in aptamer–protein complexes
Gelinas, A. D., Davies, D. R., & Janjic, N. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.01.009 · Cited by 206
Wlotzka, B., Leva, S., Eschgfäller, B., Burmeister, J., Kleinjung, F., Kaduk, C., Muhn, P., Hess-Stumpp, H., & Klussmann, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132067399 · Cited by 183
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C., Kellogg, E., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980002x · Cited by 181
Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer
Pasternak, A., Hernandez, F. J., Rasmussen, L. M., Vester, B., & Wengel, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq823 · Cited by 177
Structural Insights into the Processing of Nucleobase-Modified Nucleotides by DNA Polymerases
Hottin, A., & Marx, A. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00544 · Cited by 163
de Smidt, P. C., Doan, T. L., Falco, S. D., et al. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.17.4695 · Cited by 155
Padilla, R. M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.6.1561 · Cited by 154
Prodeus, A., Abdul‐Wahid, A., Fischer, N. W., Huang, E. H. ‐., Cydzik, M., & Gariépy, J. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.11 · Cited by 154
Gupta, S., Hirota, M., Waugh, S. M., Murakami, I., Suzuki, T., Muraguchi, M., Shibamori, M., Ishikawa, Y., Jarvis, T. C., Carter, J. D., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532580 · Cited by 151
Liposome-Anchored Vascular Endothelial Growth Factor Aptamers
Willis, M. C., Collins, B. T., Zhang, T., Green, L. S., Sebesta, D. P., Bell, C. J., Kellogg, E. A., Gill, S. C., Magallanez, A., Knauer, S., et al. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980200o · Cited by 146
Shum, K. T., & Tanner, J. A. (2008) · ChemBioChem · doi:10.1002/cbic.200800491 · Cited by 125
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
Abeydeera, N., Egli, M., Cox, N., Mercier, K., Conde, J. N., Pallan, P. S., Mizurini, D. M., Sierant, M., Hibti, F.-E., Hassell, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw725 · Cited by 122
Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand
Gelinas, A. D., Davies, D. R., Edwards, T. E., Rohloff, J. C., Carter, J. D., Zhang, C., Gupta, S., Ishikawa, Y., Hirota, M., Nakaishi, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.532697 · Cited by 109
Westmanu, E., & Strömberg, R. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.12.2430 · Cited by 108
From selection hits to clinical leads: progress in aptamer discovery
Maier, K. E., & Levy, M. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.14 · Cited by 108
Lee, C. H., Lee, S.-H., Kim, J. H., Noh, Y.-H., Noh, G., & Lee, S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.30 · Cited by 106
SINHA, N., Davis, P. W., Usman, N., PEREZ, J., Hodge, R. P., Kremsky, J. N., & Casale, R. A. (1993) · Biochimie · doi:10.1016/0300-9084(93)90019-o · Cited by 101
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
Darfeuille, F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh636 · Cited by 97
GnRH Binding RNA and DNA Spiegelmers
Leva, S., Lichte, A., Burmeister, J., Muhn, P., Jahnke, B., Fesser, D., Erfurth, J., Burgstaller, P., & Klußmann, S. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00111-4 · Cited by 95
Shiba, Y., Masuda, H., Watanabe, N., Ego, T., Takagaki, K., Ishiyama, K., Ohgi, T., & Yano, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm202 · Cited by 92
Selection of 2′-Fluoro-Modified Aptamers with Optimized Properties
Thirunavukarasu, D., Chen, T., Liu, Z., Hongdilokkul, N., & Romesberg, F. E. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b13132 · Cited by 92
Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration
Doggrell, S. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1421 · Cited by 90
A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
Trinh, T. L., Zhu, G., Xiao, X., Puszyk, W. M., Sefah, K., Wu, Q., Tan, W., & Liu, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136673 · Cited by 89
Welz, R., & Müller, S. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)02274-2 · Cited by 81
Tan, L., Neoh, K. G., Kang, E. T., Choe, W. S., & Su, X. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100173 · Cited by 80
Watson, S. R., Chang, Y.-F., O'Connell, D., WEIGAND, L., Ringquist, S., & Parma, D. H. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.63 · Cited by 79
PEGylation and Biodistribution of an anti-MUC1 Aptamer in MCF-7 Tumor-Bearing Mice
Pieve, C. D., Blackshaw, E., Missailidis, S., & Perkins, A. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300128r · Cited by 79
Fine, S. L., Martin, D. F., & Kirkpatrick, P. N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1677 · Cited by 79
A DNA Spiegelmer to staphylococcal enterotoxin B
Purschke, W. G. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg413 · Cited by 76
Nuzzi, A., Massi, A., & Dondoni, A. (2007) · QSAR & Combinatorial Science · doi:10.1002/qsar.200740079 · Cited by 75
Structural basis for specific inhibition of Autotaxin by a DNA aptamer
Kato, K., Ikeda, H., Miyakawa, S., Futakawa, S., Nonaka, Y., Fujiwara, M., Okudaira, S., Kano, K., Aoki, J., Morita, J., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3200 · Cited by 71
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF
Ashley, S. L., Xia, M., Murray, S., O’Dwyer, D. N., Grant, E. P., White, E. S., Flaherty, K. R., Martínez, F. J., & Moore, B. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159878 · Cited by 69
Molecular Selection, Modification and Development of Therapeutic Oligonucleotide Aptamers
Yu, Y., Liang, C., Lv, Q., Li, D., Xu, X., Liu, B.-Q., Lü, A., & Zhang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030358 · Cited by 65
Self-citationKawaguchi, M., Okabe, T., Okudaira, S., Nishimasu, H., Ishitani, R., Kojima, H., Nureki, O., Aoki, J., & Nagano, T. (2013) · ACS Chemical Biology · doi:10.1021/cb400150c · Cited by 62
C2′-Pyrene-Functionalized Triazole-Linked DNA: Universal DNA/RNA Hybridization Probes
Sau, S. P., & Hrdlicka, P. J. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo201845z · Cited by 61
Lee, K. Y., Kang, H., Ryu, S. H., et al. (2010) · BioMed Research International · doi:10.1155/2010/168306 · Cited by 57
Minagawa, H., Onodera, K., Fujita, H., Sakamoto, T., Akitomi, J., Kaneko, N., Shiratori, I., Kuwahara, M., Horii, K., & Waga, I. (2017) · Scientific Reports · doi:10.1038/srep42716 · Cited by 57
RNA Aptamers and Spiegelmers: Synthesis, Purification, and Post‐Synthetic PEG Conjugation
Hoffmann, S., Hoos, J. S., Klußmann, S., & Vonhoff, S. (2011) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0446s46 · Cited by 52
Aptamers as Both Drugs and Drug-Carriers
Ashrafuzzaman, M. (2014) · BioMed Research International · doi:10.1155/2014/697923 · Cited by 52
Beaucage, S. L., & Caruthers, M. H. (2000) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0303s00 · Cited by 48
Eid, C., Palko, J. W., Katilius, E., & Santiago, J. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00886 · Cited by 43
Technology evaluation: pegaptanib, Eyetech/Pfizer.
Vinores, S. A. (2003) · PubMed · Cited by 43
Conversion Strategy Using an Expanded Genetic Alphabet to Assay Nucleic Acids
Yang, Z., Durante, M. A., Glushakova, L. G., Sharma, N., Leal, N. A., Bradley, K. M., Chen, F., & Benner, S. A. (2013) · Analytical Chemistry · doi:10.1021/ac400422r · Cited by 31
Park, N. J., Wang, X., Diaz, A., Goos, D. M., Bock, C., Vaught, J. D., Sun, W., & Strom, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071703 · Cited by 21
van Eijk, L. T., Swinkels, D. W., John, A. S. E., Schwoebel, F., Fliegert, F., Summo, L., Vauléon, S., Laarakkers, J., Riecke, K., & Pickkers, P. (2013) · Critical Care · doi:10.1186/cc12290 · Cited by 9
Förster, C., Oberthüer, D., Gao, J., Eichert, A., Quast, F. G., Betzel, C., Nitsche, A., Erdmann, V. A., & Fürste, J. P. (2009) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309109029145 · Cited by 6
Expanding the application potential of DNA aptamers by their functionalization
Chumakov, A. M., Юхина, Е. С., Frolova, E. I., Kravchenko, J. E., & Chumakov, S. P. (2016) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162016010027 · Cited by 4
Cited by
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Ni, S., Zhuo, Z., Pan, Y., Yu, Y., Li, F., Liu, J., Wang, L., Wu, X., Li, D., Wan, Y., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05750 · Cited by 589
Self-citationWang, T., Chen, C., Larcher, L. M., Barrero, R. A., & Veedu, R. N. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.001 · Cited by 525
Metadata
- Authors
- Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-02
- Volume
- 18
- Issue
- 8
- Pages
- 1683
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2740994733
- Cited by
- 321
- References
- 80
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.